The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])
Condition(s):Diabetes MellitusLast Updated:July 19, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes MellitusLast Updated:July 19, 2016Completed
Condition(s):Diabetes Mellitus; Foot Ulcer; Diabetic Foot; Diabetic NeuropathiesLast Updated:July 19, 2016Completed
Condition(s):Diabetic Foot UlcersLast Updated:June 4, 2010Unknown status
Condition(s):MARTORELL’S ULCER; Hypertensive Leg Ulcer; Necrotic AngiodermatitisLast Updated:October 4, 2011Completed
Condition(s):Diabetic Foot UlcersLast Updated:December 15, 2014Completed
Condition(s):Foot Ulcer; Diabetic Foot; Skin Ulcer; Diabetic NeuropathiesLast Updated:June 8, 2011Terminated
Condition(s):Periodontal DiseasesLast Updated:December 8, 2023Recruiting
Condition(s):Platelet-Derived Growth Factor; Diabetic Foot; NeoplasmsLast Updated:June 8, 2011Completed
Condition(s):Lateral EpicondylitisLast Updated:July 2, 2019Completed
Condition(s):Diabetic Foot UlcerLast Updated:June 29, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.